Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Orthofix Medical Inc.OFIX · Entity 1975 | Director | November 02, 2018 | November 06, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Orthofix Medical Inc.
Report date November 02, 2018 · Filed November 06, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 6,479 |
Ending reported balance
After 2018-11-02 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2018-11-02 · Sale · Disposed 3,500 · Balance 7,129 F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.54 to $61.39, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Row 2 · 2018-11-02 · Sale · Disposed 650 · Balance 6,479 F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.61 to $61.87, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Row 3 · 2018-11-02 · Exercise / conversion · Acquired 4,300 · Balance 10,779 Row 4 · 2018-11-02 · Sale · Disposed 3,600 · Balance 7,179 F3: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.51 to $61.39, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. Row 5 · 2018-11-02 · Sale · Disposed 700 · Balance 6,479 F4: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.62 to $61.87, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $32.13 · Expires 2024-09-17 | Direct | 25,700 |
Reported balance
After 2018-11-02 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2018-11-02 · Exercise / conversion · Disposed 4,300 · Balance 25,700 F5: These stock options vest in 25% increments on each of September 17, 2015, 2016, 2017 and 2018. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.54 to $61.39, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.61 to $61.87, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
F3: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.51 to $61.39, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
F4: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.62 to $61.87, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4.
F5: These stock options vest in 25% increments on each of September 17, 2015, 2016, 2017 and 2018.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 02, 2018 Filed Nov 6, 2018 21:34 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Exercise / conversionStock Option (right to buy) · Derivative | 4,300 | $0.00 Strike: $32.13 | $0.00 |
DisclosureSEC source: 0001209191-18-057412 · doc4.xml · derivative · entry 6 FAULSTICK LUKE T · CIK 0001248184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,700 Underlying: Common Stock · 4,300 shares Expires 2024-09-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These stock options vest in 25% increments on each of September 17, 2015, 2016, 2017 and 2018. Read SEC document |
| November 02, 2018 Filed Nov 6, 2018 21:34 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 700 | $61.74 | $43,214.99 |
DisclosureSEC source: 0001209191-18-057412 · doc4.xml · nonDerivative · entry 5 FAULSTICK LUKE T · CIK 0001248184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,479 F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.62 to $61.87, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4. Read SEC document |
| November 02, 2018 Filed Nov 6, 2018 21:34 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 3,600 | $60.93 | $219,330.36 |
DisclosureSEC source: 0001209191-18-057412 · doc4.xml · nonDerivative · entry 4 FAULSTICK LUKE T · CIK 0001248184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,179 F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.51 to $61.39, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. Read SEC document |
| November 02, 2018 Filed Nov 6, 2018 21:34 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Exercise / conversionCommon Stock | 4,300 | $32.13 | $138,159.00 |
DisclosureSEC source: 0001209191-18-057412 · doc4.xml · nonDerivative · entry 3 FAULSTICK LUKE T · CIK 0001248184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,779 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 02, 2018 Filed Nov 6, 2018 21:34 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 650 | $61.72 | $40,120.80 |
DisclosureSEC source: 0001209191-18-057412 · doc4.xml · nonDerivative · entry 2 FAULSTICK LUKE T · CIK 0001248184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,479 F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.61 to $61.87, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| November 02, 2018 Filed Nov 6, 2018 21:34 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 3,500 | $60.93 | $213,244.85 |
DisclosureSEC source: 0001209191-18-057412 · doc4.xml · nonDerivative · entry 1 FAULSTICK LUKE T · CIK 0001248184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,129 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.54 to $61.39, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| July 17, 2018 Filed Jul 17, 2018 22:58 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 2,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-042910 · doc4.xml · nonDerivative · entry 1 FAULSTICK LUKE T · CIK 0001248184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,629 F1 · shares: Deferred Stock Unit award granted on July 2, 2018, subject to shareholder approval, which was obtained on July 17, 2018, and is subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These awards vest in full on July 2, 2019. Read SEC document |
| November 06, 2017 Filed Nov 8, 2017 21:26 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 4,800 | $51.22 | $245,845.92 |
DisclosureSEC source: 0001209191-17-059756 · doc4.xml · nonDerivative · entry 1 FAULSTICK LUKE T · CIK 0001248184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,729 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.00 to $51.57, inclusive. The reporting person undertakes to provide to Orthofix International, N.V., any security holder of Orthofix International N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| July 03, 2017 Filed Jul 10, 2017 21:57 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 3,579 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-044652 · doc4.xml · nonDerivative · entry 1 FAULSTICK LUKE T · CIK 0001248184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,529 F1 · shares: Deferred Stock Unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These awards vest in full on July 3, 2018. Vested shares of common stock will be delivered to the reporting person within 45 days after termination of service as a director. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.